| Year |
Title |
Altmetric |
| 2019
|
Defining the Hallmarks of Metastasis.
Cancer Research.
79:3011-3027.
2019
|
|
| 2017
|
Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example.
Clinical and Experimental Metastasis.
34:443-447.
2017
|
|
| 2016
|
Increased autophagic response in a population of metastatic breast cancer cells.
Oncology Letters.
12:523-529.
2016
|
|
| 2016
|
Globular adiponectin enhances invasion in human breast cancer cells.
Oncology Letters.
11:633-641.
2016
|
|
| 2016
|
SIN3A and SIN3B differentially regulate breast cancer metastasis.
Oncotarget.
7:78713-78725.
2016
|
|
| 2015
|
SOCS3 deficiency in myeloid cells promotes tumor development: Involvement of STAT3 activation and myeloid-derived suppressor cells.
Cancer Immunology Research.
3:727-740.
2015
|
|
| 2015
|
Promising oncolytic agents for metastatic breast cancer treatment..
Oncolytic Virotherapy.
4:63-73.
2015
|
|
| 2014
|
Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.
Molecular Carcinogenesis.
53:1011-1026.
2014
|
|
| 2014
|
Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cells.
PLoS ONE.
9.
2014
|
|
| 2014
|
Linking adiponectin and autophagy in the regulation of breast cancer metastasis.
The Clinical investigator.
92:1015-1023.
2014
|
|
| 2013
|
Mitochondrial Bioenergetics of Metastatic Breast Cancer Cells in Response to Dynamic Changes in Oxygen Tension: Effects of HIF-1α.
PLoS ONE.
8.
2013
|
|
| 2013
|
Unraveling the 'TGF-β paradox' one metastamir at a time.
Breast Cancer Research.
15.
2013
|
|
| 2013
|
The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression.
PLoS ONE.
8.
2013
|
|
| 2012
|
Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes.
Cancer and Metastasis Reviews.
31:641-651.
2012
|
|
| 2012
|
Clinical significance of KISS1 protein expression for brain invasion and metastasis.
Cancer.
118:2096-2105.
2012
|
|
| 2012
|
Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.
Clinical and Experimental Metastasis.
29:315-325.
2012
|
|
| 2012
|
The influence of the cancer microenvironment on the process of metastasis..
International Journal of Breast Cancer.
2012:756257.
2012
|
|
| 2011
|
Protein signatures in human MDA-MB-231 breast cancer cells indicating a more invasive phenotype following knockdown of human endometase/matrilysin-2 by siRNA.
Journal of Cancer.
2:165-176.
2011
|
|
| 2011
|
Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression.
FEBS Letters.
585:3185-3190.
2011
|
|
| 2011
|
Heparanase-mediated loss of nuclear syndecan-1 enhances Histone Acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype.
Journal of Biological Chemistry.
286:30377-30383.
2011
|
|
| 2011
|
Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines.
Clinical and Experimental Metastasis.
28:437-449.
2011
|
|
| 2011
|
Metastasis suppressors and the tumor microenvironment.
Seminars in Cancer Biology.
21:113-122.
2011
|
|
| 2011
|
Metastasis suppressor genes. At the interface between the environment and tumor cell growth.
International Review of Cell and Molecular Biology.
286:107-180.
2011
|
|
| 2010
|
Linking metastasis suppression with metastamir regulation.
Chinese Journal of Lung Cancer.
13:140-143.
2010
|
|
| 2009
|
Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.
International Journal of Cancer.
125:1778-1785.
2009
|
|
| 2009
|
Metastamir: The field of metastasis-regulatory microRNA is spreading.
Cancer Research.
69:7495-7498.
2009
|
|
| 2009
|
Linking metastasis suppression with metastamiR regulation.
Cell Cycle.
8:2673-2675.
2009
|
|
| 2009
|
Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.
Clinical and Experimental Metastasis.
26:527-533.
2009
|
|
| 2009
|
Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.
Oncology Reports.
21:761-767.
2009
|
|
| 2009
|
Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.
Cancer Letters.
276:32-37.
2009
|
|
| 2009
|
Breast cancer metastasis suppressor 1 up-regulates miR-146, Which suppresses breast cancer metastasis.
Cancer Research.
69:1279-1283.
2009
|
|
| 2009
|
Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.
Clinical and Experimental Metastasis.
26:89-96.
2009
|
|
| 2008
|
Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.
Journal of Biological Chemistry.
283:28354-28360.
2008
|
|
| 2008
|
Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
Journal of Biological Chemistry.
283:7438-7444.
2008
|
|
| 2008
|
BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.
American Journal of Pathology.
172:809-817.
2008
|
|
| 2007
|
A MSC-ing link in metastasis?.
Nature Medicine.
13:1289-1291.
2007
|
|
| 2007
|
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy.
JNCI: Journal of the National Cancer Institute.
99:309-321.
2007
|
|
| 2006
|
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.
Biochemical and Biophysical Research Communications.
348:1429-1435.
2006
|
|
| 2006
|
Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
Cancer Letters.
235:260-265.
2006
|
|
| 2006
|
Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases.
Current Topics in Medicinal Chemistry.
6:289-316.
2006
|
|
| 2005
|
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
Biochemical Journal.
392:527-536.
2005
|
|
| 2004
|
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
Biochemical Journal.
377:775-779.
2004
|
|
| 2004
|
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities..
Biochemical Journal.
377:775-779.
2004
|
|
| 2003
|
The Intermediate S1′ Pocket of the Endometase/ Matrilysin-2 Active Site Revealed by Enzyme Inhibition Kinetic Studies, Protein Sequence Analyses, and Homology Modeling.
Journal of Biological Chemistry.
278:51646-51653.
2003
|
|
| 2002
|
Protein engineering and properties of human metalloproteinase and thrombospondin 1.
Biochemical and Biophysical Research Communications.
293:478-488.
2002
|
|
| 2001
|
Development and characterization of a new polyclonal antibody specifically against tissue inhibitor of metalloproteinases 4 in human breast cancer.
Biochemical and Biophysical Research Communications.
281:166-171.
2001
|
|
| 2001
|
Preparation of 2-phenyl-4-(1h-pyrazol-5-yl)quinolines.
Organic Preparations and Procedures International: The New Journal for Organic Synthesis.
33:91-95.
2001
|
|
| 1999
|
A new series of proton/charge transfer molecules: Synthesis and spectral studies of 2-(5-Aryl-1-carbomethoxy-1H-pyrazol-3-yl)phenols.
Photochemistry and Photobiology.
70:176-183.
1999
|
|
| 1999
|
Preparation of N-aryl-4-oxo-4H-1-benzothiopyran-2-acetamides from trilithiated acetoacetanilides and lithiated methyl thiosalicylate.
Canadian Journal of Chemistry.
77:94-97.
1999
|
|
| 1999
|
The preparation of 2-(1-phenyl-5-phenyl or 5-substituted phenyl-1H- pyrazol-3-yl)phenols from trilithiated 2'-hydroxyacetophenone phenylhydrazone and aromatic esters.
Synthetic Communications.
29:495-506.
1999
|
|
| 1999
|
The preparation of 2-[4,5-dihydro-3-aryl-5-isoxazolyl]-phenols from C(α),O-dilithiooximes and lithiated hydroxyaryl aldehydes.
Synthetic Communications.
29:1977-1988.
1999
|
|
| 1999
|
The preparation of 4,5-dihydro-2H-benz[e]indazoles from dilithiated 2- tetralone phenylhydrazone and aromatic esters.
Journal of Heterocyclic Chemistry.
36:1231-1233.
1999
|
|
| 1998
|
Hydroxyaryl-isoxazoles: Synthesis and related studies.
Chemist.
75:7-11.
1998
|
|
| 1998
|
A New Preparation of Substituted 4H-1-Benzothiopyran-4-ones from C(α),N-Benzoylhydrazones or C(α),N-Carboalkoxyhydrazones and Methyl Thiosalicylate.
Journal of Heterocyclic Chemistry.
35:45-48.
1998
|
|
| 1998
|
The preparation of 2-(4-oxo-4h-1-benzopyran-2-yl)- 1-phenylethanones by the condensation/cyclization of dilithiated 1-benzoylacetone with lithiated methyl salicylates.
Synthetic Communications.
28:1547-1554.
1998
|
|
| 1998
|
The preparation of 4-oxo-N-aryl-4H-1-benzopyran-2-acetamides by the condensation/cyclization of trilithiated acetoacetanilides with lithiated methyl salicylates.
Journal of Heterocyclic Chemistry.
35:1357-1359.
1998
|
|
